{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:00:57Z","timestamp":1791900057958,"version":"4.3.4"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL144125"],"award-info":[{"award-number":["R01HL144125"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL147662"],"award-info":[{"award-number":["R01HL147662"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11010-021-04061-0","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T15:05:04Z","timestamp":1611587104000},"page":"1915-1928","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Mitochondrial DAMPs and altered mitochondrial dynamics in OxLDL burden in atherosclerosis"],"prefix":"10.1007","volume":"476","author":[{"given":"Bisma","family":"Khwaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finosh G.","family":"Thankam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5445-0013","authenticated-orcid":false,"given":"Devendra K.","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"4061_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","volume":"118","author":"H William","year":"2016","unstructured":"William H, Ben L, Paul S et al (2016) Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res 118:535\u2013546. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.307611","journal-title":"Circ Res"},{"key":"4061_CR2","doi-asserted-by":"publisher","unstructured":"Virani SS, Alonso A, Benjamin EJ et al (2020) Heart disease and stroke statistics\u20142020 update: a report from the American Heart Association. Circulation. https:\/\/doi.org\/10.1161\/CIR.0000000000000757","DOI":"10.1161\/CIR.0000000000000757"},{"key":"4061_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.freeradbiomed.2016.06.011","volume":"100","author":"EPK Yu","year":"2016","unstructured":"Yu EPK, Bennett MR (2016) The role of mitochondrial DNA damage in the development of atherosclerosis. Free Radic Biol Med 100:223\u2013230. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.06.011","journal-title":"Free Radic Biol Med"},{"key":"4061_CR4","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1161\/ATVBAHA.117.310042","volume":"37","author":"PK Yu Emma","year":"2017","unstructured":"Yu Emma PK, Johannes R, Haixiang Y et al (2017) Mitochondrial respiration is reduced in atherosclerosis, promoting necrotic core formation and reducing relative fibrous cap thickness. Arterioscler Thromb Vasc Biol 37:2322\u20132332. https:\/\/doi.org\/10.1161\/ATVBAHA.117.310042","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4061_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s11883-012-0237-0","volume":"14","author":"M Hulsmans","year":"2012","unstructured":"Hulsmans M, Van Dooren E, Holvoet P (2012) Mitochondrial reactive oxygen species and risk of atherosclerosis. Curr Atheroscler Rep 14:264\u2013276. https:\/\/doi.org\/10.1007\/s11883-012-0237-0","journal-title":"Curr Atheroscler Rep"},{"key":"4061_CR6","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1161\/01.RES.0000258450.44413.96","volume":"100","author":"NR Madamanchi","year":"2007","unstructured":"Madamanchi NR, Runge MS (2007) Mitochondrial dysfunction in atherosclerosis. Circulation Res 100:460\u2013473. https:\/\/doi.org\/10.1161\/01.RES.0000258450.44413.96","journal-title":"Circulation Res"},{"key":"4061_CR7","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1089\/ars.2015.6407","volume":"23","author":"K Nakahira","year":"2015","unstructured":"Nakahira K, Hisata S, Choi AMK (2015) The roles of mitochondrial damage-associated molecular patterns in diseases. Antioxidants Redox Signal 23:1329\u20131350. https:\/\/doi.org\/10.1089\/ars.2015.6407","journal-title":"Antioxidants Redox Signal"},{"key":"4061_CR8","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nri2873","volume":"10","author":"GY Chen","year":"2010","unstructured":"Chen GY, Nu\u00f1ez G (2010) Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10:826\u2013837. https:\/\/doi.org\/10.1038\/nri2873","journal-title":"Nat Rev Immunol"},{"key":"4061_CR9","doi-asserted-by":"publisher","unstructured":"Rai V, Agrawal DK (2017) The role of damage- and pathogen-associated molecular patterns in inflammation-mediated vulnerability of atherosclerotic plaques1. Can J Physiol Pharmaco. https:\/\/doi.org\/10.1139\/cjpp-2016-0664","DOI":"10.1139\/cjpp-2016-0664"},{"key":"4061_CR10","doi-asserted-by":"publisher","unstructured":"Thankam FG, Ayoub JG, Ahmed MMR et al (2020) Association of hypoxia and mitochondrial damage associated molecular patterns in the pathogenesis of vein graft failure: a pilot study. Transl Res. https:\/\/doi.org\/10.1016\/j.trsl.2020.08.010","DOI":"10.1016\/j.trsl.2020.08.010"},{"key":"4061_CR11","doi-asserted-by":"publisher","first-page":"R911","DOI":"10.1016\/j.cub.2015.07.055","volume":"25","author":"JM Archibald","year":"2015","unstructured":"Archibald JM (2015) Endosymbiosis and eukaryotic cell evolution. Curr Biol 25:R911\u2013R921. https:\/\/doi.org\/10.1016\/j.cub.2015.07.055","journal-title":"Curr Biol"},{"key":"4061_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mito.2017.12.001","volume":"41","author":"CS Dela Cruz","year":"2018","unstructured":"Dela Cruz CS, Kang M-J (2018) Mitochondrial dysfunction and damage associated molecular patterns (DAMPs) in chronic inflammatory diseases. Mitochondrion 41:37\u201344. https:\/\/doi.org\/10.1016\/j.mito.2017.12.001","journal-title":"Mitochondrion"},{"key":"4061_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1161\/CIRCRESAHA.114.302153","volume":"114","author":"Y Wang","year":"2014","unstructured":"Wang Y, Wang GZ, Rabinovitch PS, Tabas I (2014) Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-\u03baB\u2013mediated inflammation in macrophages. Circ Res 114:421\u2013433. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.302153","journal-title":"Circ Res"},{"key":"4061_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-016-0546-5","volume":"111","author":"AO Kadlec","year":"2016","unstructured":"Kadlec AO, Beyer AM, Ait-Aissa K, Gutterman DD (2016) Mitochondrial signaling in the vascular endothelium: beyond reactive oxygen species. Basic Res Cardiol 111:26. https:\/\/doi.org\/10.1007\/s00395-016-0546-5","journal-title":"Basic Res Cardiol"},{"key":"4061_CR15","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/ATVBAHA.117.309228","volume":"37","author":"WN Nowak","year":"2017","unstructured":"Nowak WN, Deng J, Ruan XZ, Xu Q (2017) Reactive oxygen species generation and atherosclerosis. Arterioscler Thromb Vasc Biol 37:e41\u2013e52. https:\/\/doi.org\/10.1161\/ATVBAHA.117.309228","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4061_CR16","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1161\/CIRCULATIONAHA.113.002271","volume":"128","author":"E Yu","year":"2013","unstructured":"Yu E, Calvert PA, Mercer JR et al (2013) Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans. Circulation 128:702\u2013712. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.002271","journal-title":"Circulation"},{"key":"4061_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.atherosclerosis.2006.07.018","volume":"192","author":"V Ferreira","year":"2007","unstructured":"Ferreira V, van Dijk KW, Groen AK et al (2007) Macrophage-specific inhibition of NF-\u03baB activation reduces foam-cell formation. Atherosclerosis 192:283\u2013290. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.07.018","journal-title":"Atherosclerosis"},{"key":"4061_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2015.03.004","volume":"70","author":"X-H Yu","year":"2015","unstructured":"Yu X-H, Zheng X-L, Tang C-K (2015) Nuclear factor-\u03baB activation as a pathological mechanism of lipid metabolism and atherosclerosis. Adv Clin Chem 70:1\u201330. https:\/\/doi.org\/10.1016\/bs.acc.2015.03.004","journal-title":"Adv Clin Chem"},{"key":"4061_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/SHK.0b013e3181cd8c08","volume":"34","author":"Q Zhang","year":"2010","unstructured":"Zhang Q, Itagaki K, Hauser CJ (2010) Mitochondrial DNA is released by shock and activates neutrophils via p38 map kinase. Shock 34:55\u201359. https:\/\/doi.org\/10.1097\/SHK.0b013e3181cd8c08","journal-title":"Shock"},{"key":"4061_CR20","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/srep01077","volume":"3","author":"Z Ding","year":"2013","unstructured":"Ding Z, Liu S, Wang X et al (2013) Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis. Sci Rep 3:1077. https:\/\/doi.org\/10.1038\/srep01077","journal-title":"Sci Rep"},{"key":"4061_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41586-018-0372-z","volume":"560","author":"Z Zhong","year":"2018","unstructured":"Zhong Z, Liang S, Sanchez-Lopez E et al (2018) New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature 560:198\u2013203. https:\/\/doi.org\/10.1038\/s41586-018-0372-z","journal-title":"Nature"},{"key":"4061_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou R, Yazdi AS, Menu P, Tschopp J (2011) A role for mitochondria in NLRP3 inflammasome activation. Nature 469:221\u2013225. https:\/\/doi.org\/10.1038\/nature09663","journal-title":"Nature"},{"key":"4061_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jjcc.2014.10.012","volume":"66","author":"OM Bhat","year":"2015","unstructured":"Bhat OM, Kumar PU, Giridharan NV et al (2015) Interleukin-18-induced atherosclerosis involves CD36 and NF-\u03baB crosstalk in Apo E\u2212\/\u2212 mice. J Cardiol 66:28\u201335. https:\/\/doi.org\/10.1016\/j.jjcc.2014.10.012","journal-title":"J Cardiol"},{"key":"4061_CR24","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1016\/j.atherosclerosis.2007.01.021","volume":"195","author":"C Espinola-Klein","year":"2007","unstructured":"Espinola-Klein C, Rupprecht HJ, Bickel C et al (2007) Inflammation, atherosclerotic burden and cardiovascular prognosis. Atherosclerosis 195:e126\u2013e134. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.01.021","journal-title":"Atherosclerosis"},{"key":"4061_CR25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature14156","volume":"520","author":"AP West","year":"2015","unstructured":"West AP, Khoury-Hanold W, Staron M et al (2015) Mitochondrial DNA stress primes the antiviral innate immune response. Nature 520:553\u2013557. https:\/\/doi.org\/10.1038\/nature14156","journal-title":"Nature"},{"key":"4061_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.cyto.2015.09.016","volume":"77","author":"MCS Boshuizen","year":"2016","unstructured":"Boshuizen MCS, Hoeksema MA, Neele AE et al (2016) Interferon-\u03b2 promotes macrophage foam cell formation by altering both cholesterol influx and efflux mechanisms. Cytokine 77:220\u2013226. https:\/\/doi.org\/10.1016\/j.cyto.2015.09.016","journal-title":"Cytokine"},{"key":"4061_CR27","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/art.30165","volume":"63","author":"J Li","year":"2011","unstructured":"Li J, Fu Q, Cui H et al (2011) Interferon-\u03b1 priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-\u03b1 and atherosclerosis in lupus. Arthritis Rheum 63:492\u2013502. https:\/\/doi.org\/10.1002\/art.30165","journal-title":"Arthritis Rheum"},{"key":"4061_CR28","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1161\/CIRCULATIONAHA.106.642801","volume":"114","author":"A Niessner","year":"2006","unstructured":"Niessner A, Sato K, Chaikof EL et al (2006) Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-\u03b1. Circulation 114:2482\u20132489. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.642801","journal-title":"Circulation"},{"key":"4061_CR29","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cmet.2010.06.008","volume":"12","author":"P Goossens","year":"2010","unstructured":"Goossens P, Gijbels MJJ, Zernecke A et al (2010) Myeloid Type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. Cell Metab 12:142\u2013153. https:\/\/doi.org\/10.1016\/j.cmet.2010.06.008","journal-title":"Cell Metab"},{"key":"4061_CR30","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/nm1459","volume":"12","author":"MCH Clarke","year":"2006","unstructured":"Clarke MCH, Figg N, Maguire JJ et al (2006) Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 12:1075\u20131080. https:\/\/doi.org\/10.1038\/nm1459","journal-title":"Nat Med"},{"key":"4061_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.5483\/BMBRep.2019.52.2.282","volume":"52","author":"S-M Kim","year":"2019","unstructured":"Kim S-M, Huh J-W, Kim E-Y et al (2019) Endothelial dysfunction induces atherosclerosis: increased aggrecan expression promotes apoptosis in vascular smooth muscle cells. BMB Rep 52:145\u2013150. https:\/\/doi.org\/10.5483\/BMBRep.2019.52.2.282","journal-title":"BMB Rep"},{"key":"4061_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0741-5214(02)75463-3","volume":"38","author":"AS Dhume","year":"2003","unstructured":"Dhume AS, Agrawal DK (2003) Inability of vascular smooth muscle cells to proceed beyond S phase of cell cycle, and increased apoptosis in symptomatic carotid artery disease1 1Competition of interest: none. J Vasc Surg 38:155\u2013161. https:\/\/doi.org\/10.1016\/S0741-5214(02)75463-3","journal-title":"J Vasc Surg"},{"key":"4061_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10016-001-0331-1","volume":"17","author":"AS Dhume","year":"2003","unstructured":"Dhume AS, Soundararajan K, Hunter WJ, Agrawal DK (2003) Comparison of vascular smooth muscle cell apoptosis and fibrous cap morphology in symptomatic and asymptomatic carotid artery disease. Ann Vasc Surg 17:1\u20138. https:\/\/doi.org\/10.1007\/s10016-001-0331-1","journal-title":"Ann Vasc Surg"},{"key":"4061_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cjca.2016.12.010","volume":"33","author":"L Gonzalez","year":"2017","unstructured":"Gonzalez L, Trigatti BL (2017) Macrophage apoptosis and necrotic core development in atherosclerosis: a rapidly advancing field with clinical relevance to imaging and therapy. Can J Cardiol 33:303\u2013312. https:\/\/doi.org\/10.1016\/j.cjca.2016.12.010","journal-title":"Can J Cardiol"},{"key":"4061_CR35","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1161\/ATVBAHA.115.306132","volume":"35","author":"K Yin","year":"2015","unstructured":"Yin K, You Y, Swier V et al (2015) Vitamin D Protects against atherosclerosis via regulation of cholesterol efflux and macrophage polarization in hypercholesterolemic swine. Arterioscler Thromb Vasc Biol 35:2432\u20132442. https:\/\/doi.org\/10.1161\/ATVBAHA.115.306132","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4061_CR36","doi-asserted-by":"publisher","unstructured":"Eleftheriadis T, Pissas G, Liakopoulos V, Stefanidis I (2016) Cytochrome c as a potentially clinical useful marker of mitochondrial and cellular damage. Front Immunol 7. https:\/\/doi.org\/10.3389\/fimmu.2016.00279","DOI":"10.3389\/fimmu.2016.00279"},{"key":"4061_CR37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cccn.2003.12.011","volume":"342","author":"N Adachi","year":"2004","unstructured":"Adachi N, Hirota M, Hamaguchi M et al (2004) Serum cytochrome c level as a prognostic indicator in patients with systemic inflammatory response syndrome. Clin Chim Acta 342:127\u2013136. https:\/\/doi.org\/10.1016\/j.cccn.2003.12.011","journal-title":"Clin Chim Acta"},{"key":"4061_CR38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1385\/ABAB:90:2:97","volume":"90","author":"T Alleyne","year":"2001","unstructured":"Alleyne T, Joseph J, Sampson V (2001) Cytochrome-c detection. Appl Biochem Biotechnol 90:97\u2013105. https:\/\/doi.org\/10.1385\/ABAB:90:2:97","journal-title":"Appl Biochem Biotechnol"},{"key":"4061_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11255-013-0417-z","volume":"46","author":"T Eleftheriadis","year":"2014","unstructured":"Eleftheriadis T, Pissas G, Antoniadi G et al (2014) Damage-associated molecular patterns derived from mitochondria may contribute to the hemodialysis-associated inflammation. Int Urol Nephrol 46:107\u2013112. https:\/\/doi.org\/10.1007\/s11255-013-0417-z","journal-title":"Int Urol Nephrol"},{"key":"4061_CR40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/rheumatology\/keh406","volume":"44","author":"R Pullerits","year":"2005","unstructured":"Pullerits R, Bokarewa M, Jonsson I-M et al (2005) Extracellular cytochrome c, a mitochondrial apoptosis-related protein, induces arthritis. Rheumatology (Oxford) 44:32\u201339. https:\/\/doi.org\/10.1093\/rheumatology\/keh406","journal-title":"Rheumatology (Oxford)"},{"key":"4061_CR41","doi-asserted-by":"publisher","first-page":"129400","DOI":"10.1016\/j.bbagen.2019.07.009","volume":"1863","author":"TJ Wenzel","year":"2019","unstructured":"Wenzel TJ, Bajwa E, Klegeris A (2019) Cytochrome c can be released into extracellular space and modulate functions of human astrocytes in a toll-like receptor 4-dependent manner. Biochim Biophys Acta (BBA): General Subjects 1863:129400. https:\/\/doi.org\/10.1016\/j.bbagen.2019.07.009","journal-title":"Biochim Biophys Acta (BBA): General Subjects"},{"key":"4061_CR42","doi-asserted-by":"crossref","unstructured":"Roshan MHK, Tambo A, Pace NP (2016) The role of TLR2, TLR4, and TLR9 in the pathogenesis of atherosclerosis. Int J Inflamm https:\/\/www.hindawi.com\/journals\/iji\/2016\/1532832\/. Accessed 1 Jul 2020","DOI":"10.1155\/2016\/1532832"},{"key":"4061_CR43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ni.1836","volume":"11","author":"CR Stewart","year":"2010","unstructured":"Stewart CR, Stuart LM, Wilkinson K et al (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11:155\u2013161. https:\/\/doi.org\/10.1038\/ni.1836","journal-title":"Nat Immunol"},{"key":"4061_CR44","doi-asserted-by":"publisher","first-page":"4518","DOI":"10.1021\/bi701962c","volume":"47","author":"J Liu","year":"2008","unstructured":"Liu J, Epand RF, Durrant D et al (2008) Role of phospholipid scramblase 3 in the regulation of tumor necrosis factor-alpha-induced apoptosis. Biochemistry 47:4518\u20134529. https:\/\/doi.org\/10.1021\/bi701962c","journal-title":"Biochemistry"},{"key":"4061_CR45","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/eurheartj\/ehu047","volume":"35","author":"CF Wenceslau","year":"2014","unstructured":"Wenceslau CF, McCarthy CG, Szasz T et al (2014) Mitochondrial damage-associated molecular patterns and vascular function. Eur Heart J 35:1172\u20131177. https:\/\/doi.org\/10.1093\/eurheartj\/ehu047","journal-title":"Eur Heart J"},{"key":"4061_CR46","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1161\/01.ATV.0000233333.07991.4a","volume":"26","author":"A Tuominen","year":"2006","unstructured":"Tuominen A, Miller Yury I, Hansen Lotte F et al (2006) A natural antibody to oxidized cardiolipin binds to oxidized low-density lipoprotein, apoptotic cells, and atherosclerotic lesions. Arterioscler Thromb Vasc Biol 26:2096\u20132102. https:\/\/doi.org\/10.1161\/01.ATV.0000233333.07991.4a","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4061_CR47","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.amjcard.2007.12.010","volume":"101","author":"I Marai","year":"2008","unstructured":"Marai I, Shechter M, Langevitz P et al (2008) Anti-cardiolipin antibodies and endothelial function in patients with coronary artery disease. Am J Cardiol 101:1094\u20131097. https:\/\/doi.org\/10.1016\/j.amjcard.2007.12.010","journal-title":"Am J Cardiol"},{"key":"4061_CR48","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1182\/blood.V97.2.459","volume":"97","author":"D Pratic\u00f2","year":"2001","unstructured":"Pratic\u00f2 D, Tangirala RK, H\u00f6rkk\u00f6 S et al (2001) Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F2\u03b1-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E. Blood 97:459\u2013464. https:\/\/doi.org\/10.1182\/blood.V97.2.459","journal-title":"Blood"},{"key":"4061_CR49","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ijcard.2019.10.042","volume":"300","author":"C Selmi","year":"2020","unstructured":"Selmi C, De Santis M, Battezzati PM et al (2020) Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population. Int J Cardiol 300:209\u2013213. https:\/\/doi.org\/10.1016\/j.ijcard.2019.10.042","journal-title":"Int J Cardiol"},{"key":"4061_CR50","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.4049\/jimmunol.1000921","volume":"186","author":"M Dieud\u00e9","year":"2011","unstructured":"Dieud\u00e9 M, Striegl H, Tyznik AJ et al (2011) Cardiolipin binds to CD1d and stimulates CD1d-restricted \u03b3\u03b4 T cells in the normal murine repertoire. J Immunol 186:4771\u20134781. https:\/\/doi.org\/10.4049\/jimmunol.1000921","journal-title":"J Immunol"},{"key":"4061_CR51","doi-asserted-by":"publisher","first-page":"L303","DOI":"10.1152\/ajplung.00038.2016","volume":"311","author":"JR Buland","year":"2016","unstructured":"Buland JR, Wasserloos KJ, Tyurin VA et al (2016) Biosynthesis of oxidized lipid mediators via lipoprotein-associated phospholipase A2 hydrolysis of extracellular cardiolipin induces endothelial toxicity. Am J Physiol-Lung Cell Mol Physiol 311:L303\u2013L316. https:\/\/doi.org\/10.1152\/ajplung.00038.2016","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"key":"4061_CR52","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.atherosclerosis.2014.05.913","volume":"235","author":"M Wan","year":"2014","unstructured":"Wan M, Hua X, Su J et al (2014) Oxidized but not native cardiolipin has pro-inflammatory effects, which are inhibited by Annexin A5. Atherosclerosis 235:592\u2013598. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.05.913","journal-title":"Atherosclerosis"},{"key":"4061_CR53","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1073\/pnas.0602414103","volume":"103","author":"H Qiu","year":"2006","unstructured":"Qiu H, Gabrielsen A, Agardh HE et al (2006) Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci U S A 103:8161\u20138166. https:\/\/doi.org\/10.1073\/pnas.0602414103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4061_CR54","doi-asserted-by":"publisher","first-page":"ra95","DOI":"10.1126\/scisignal.aaa6179","volume":"8","author":"K Balasubramanian","year":"2015","unstructured":"Balasubramanian K, Maeda A, Lee JS et al (2015) Dichotomous roles for externalized cardiolipin in extracellular signaling: promotion of phagocytosis and attenuation of innate immunity. Sci Signal 8:ra95\u2013ra95. https:\/\/doi.org\/10.1126\/scisignal.aaa6179","journal-title":"Sci Signal"},{"key":"4061_CR55","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.immuni.2013.08.001","volume":"39","author":"SS Iyer","year":"2013","unstructured":"Iyer SS, He Q, Janczy JR et al (2013) Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity 39:311\u2013323. https:\/\/doi.org\/10.1016\/j.immuni.2013.08.001","journal-title":"Immunity"},{"key":"4061_CR56","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s12026-014-8552-x","volume":"60","author":"E Bodolay","year":"2014","unstructured":"Bodolay E, Proh\u00e1szka Z, Paragh G et al (2014) Increased levels of anti-heat-shock protein 60 (anti-Hsp60) indicate endothelial dysfunction, atherosclerosis and cardiovascular diseases in patients with mixed connective tissue disease. Immunol Res 60:50\u201359. https:\/\/doi.org\/10.1007\/s12026-014-8552-x","journal-title":"Immunol Res"},{"key":"4061_CR57","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1161\/01.STR.0000189632.98944.ab","volume":"36","author":"Q Xiao","year":"2005","unstructured":"Xiao Q, Mandal K, Schett G et al (2005) Association of serum-soluble heat shock protein 60 with carotid atherosclerosis. Stroke 36:2571\u20132576. https:\/\/doi.org\/10.1161\/01.STR.0000189632.98944.ab","journal-title":"Stroke"},{"key":"4061_CR58","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1161\/01.ATV.0000029720.59649.50","volume":"22","author":"Q Xu","year":"2002","unstructured":"Xu Q (2002) Role of heat shock proteins in atherosclerosis. Arterioscler Thromb Vasc Biol 22:1547\u20131559. https:\/\/doi.org\/10.1161\/01.ATV.0000029720.59649.50","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4061_CR59","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1161\/01.CIR.102.1.14","volume":"102","author":"Q Xu","year":"2000","unstructured":"Xu Q, Schett G, Perschinka H et al (2000) Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 102:14\u201320. https:\/\/doi.org\/10.1161\/01.CIR.102.1.14","journal-title":"Circulation"},{"key":"4061_CR60","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1161\/CIRCRESAHA.116.301135","volume":"116","author":"S Zimmer","year":"2015","unstructured":"Zimmer S, Grebe A, Latz E (2015) Danger signaling in atherosclerosis. Circ Res 116:323\u2013340. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.301135","journal-title":"Circ Res"},{"key":"4061_CR61","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/S0002-9440(10)64301-5","volume":"162","author":"B Metzler","year":"2003","unstructured":"Metzler B, Abia R, Ahmad M et al (2003) Activation of heat shock transcription factor 1 in atherosclerosis. Am J Pathol 162:1669\u20131676. https:\/\/doi.org\/10.1016\/S0002-9440(10)64301-5","journal-title":"Am J Pathol"},{"key":"4061_CR62","doi-asserted-by":"publisher","first-page":"15352","DOI":"10.1038\/srep15352","volume":"5","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Zhang C, Wei X et al (2015) Heat shock protein 60 stimulates the migration of vascular smooth muscle cells via Toll-like receptor 4 and ERK MAPK activation. Sci Rep 5:15352. https:\/\/doi.org\/10.1038\/srep15352","journal-title":"Sci Rep"},{"key":"4061_CR63","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12974-018-1214-5","volume":"15","author":"S Swaroop","year":"2018","unstructured":"Swaroop S, Mahadevan A, Shankar SK et al (2018) HSP60 critically regulates endogenous IL-1\u03b2 production in activated microglia by stimulating NLRP3 inflammasome pathway. J Neuroinflamm 15:177. https:\/\/doi.org\/10.1186\/s12974-018-1214-5","journal-title":"J Neuroinflamm"},{"key":"4061_CR64","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1097\/CCM.0b013e3181a001ae","volume":"37","author":"ED Crouser","year":"2009","unstructured":"Crouser ED, Shao G, Julian MW et al (2009) Monocyte activation by necrotic cells is promoted by mitochondrial proteins and formyl peptide receptors. Crit Care Med 37:2000\u20132009. https:\/\/doi.org\/10.1097\/CCM.0b013e3181a001ae","journal-title":"Crit Care Med"},{"key":"4061_CR65","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.mcn.2014.04.003","volume":"60","author":"JP Little","year":"2014","unstructured":"Little JP, Simtchouk S, Schindler SM et al (2014) Mitochondrial transcription factor A (Tfam) is a pro-inflammatory extracellular signaling molecule recognized by brain microglia. Mol Cell Neurosci 60:88\u201396. https:\/\/doi.org\/10.1016\/j.mcn.2014.04.003","journal-title":"Mol Cell Neurosci"},{"key":"4061_CR66","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mcn.2018.04.005","volume":"89","author":"SM Schindler","year":"2018","unstructured":"Schindler SM, Frank MG, Annis JL et al (2018) Pattern recognition receptors mediate pro-inflammatory effects of extracellular mitochondrial transcription factor A (TFAM). Mol Cell Neurosci 89:71\u201379. https:\/\/doi.org\/10.1016\/j.mcn.2018.04.005","journal-title":"Mol Cell Neurosci"},{"key":"4061_CR67","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4049\/jimmunol.1101375","volume":"189","author":"MW Julian","year":"2012","unstructured":"Julian MW, Shao G, Bao S et al (2012) Mitochondrial transcription Factor A serves as a danger signal by augmenting plasmacytoid dendritic cell responses to DNA. J Immunol 189:433\u2013443. https:\/\/doi.org\/10.4049\/jimmunol.1101375","journal-title":"J Immunol"},{"key":"4061_CR68","doi-asserted-by":"publisher","first-page":"e72354","DOI":"10.1371\/journal.pone.0072354","volume":"8","author":"MW Julian","year":"2013","unstructured":"Julian MW, Shao G, VanGundy ZC et al (2013) Mitochondrial transcription factor A, an endogenous danger signal, promotes TNF\u03b1 release via RAGE- and TLR9-responsive plasmacytoid dendritic cells. PLoS One 8:e72354. https:\/\/doi.org\/10.1371\/journal.pone.0072354","journal-title":"PLoS One"},{"key":"4061_CR69","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3892\/ijmm.2012.959","volume":"30","author":"WW Chaung","year":"2012","unstructured":"Chaung WW, Wu R, Ji Y et al (2012) Mitochondrial transcription factor A is a proinflammatory mediator in hemorrhagic shock. Int J Mol Med 30:199\u2013203. https:\/\/doi.org\/10.3892\/ijmm.2012.959","journal-title":"Int J Mol Med"},{"key":"4061_CR70","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1136\/thoraxjnl-2017-210030","volume":"72","author":"DA Dorward","year":"2017","unstructured":"Dorward DA, Lucas CD, Doherty MK et al (2017) Novel role for endogenous mitochondrial formylated peptide-driven formyl peptide receptor 1 signalling in acute respiratory distress syndrome. Thorax 72:928\u2013936. https:\/\/doi.org\/10.1136\/thoraxjnl-2017-210030","journal-title":"Thorax"},{"key":"4061_CR71","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pupt.2016.02.005","volume":"37","author":"CF Wenceslau","year":"2016","unstructured":"Wenceslau CF, Szasz T, McCarthy CG et al (2016) Mitochondrial N-formyl peptides cause airway contraction and lung neutrophil infiltration via formyl peptide receptor activation. Pulmonary Pharmacol Ther 37:49\u201356. https:\/\/doi.org\/10.1016\/j.pupt.2016.02.005","journal-title":"Pulmonary Pharmacol Ther"},{"key":"4061_CR72","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.cytogfr.2006.09.009","volume":"17","author":"I Migeotte","year":"2006","unstructured":"Migeotte I, Communi D, Parmentier M (2006) Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev 17:501\u2013519. https:\/\/doi.org\/10.1016\/j.cytogfr.2006.09.009","journal-title":"Cytokine Growth Factor Rev"},{"key":"4061_CR73","doi-asserted-by":"publisher","unstructured":"Martinez-Quinones P, Komic A, McCarthy CG et al (2019) Targeting endothelial barrier dysfunction caused by circulating bacterial and mitochondrial N-formyl peptides with deformylase. Front Immunol 10. https:\/\/doi.org\/10.3389\/fimmu.2019.01270","DOI":"10.3389\/fimmu.2019.01270"},{"key":"4061_CR74","doi-asserted-by":"publisher","first-page":"H768","DOI":"10.1152\/ajpheart.00779.2014","volume":"308","author":"CF Wenceslau","year":"2015","unstructured":"Wenceslau CF, McCarthy CG, Szasz T et al (2015) Mitochondrial N-formyl peptides induce cardiovascular collapse and sepsis-like syndrome. Am J Physiol-Heart Circ Physiol 308:H768\u2013H777. https:\/\/doi.org\/10.1152\/ajpheart.00779.2014","journal-title":"Am J Physiol-Heart Circ Physiol"},{"key":"4061_CR75","first-page":"1","volume":"26","author":"T Hosokawa","year":"2011","unstructured":"Hosokawa T, Kumon Y, Kobayashi T et al (2011) Neutrophil infiltration and oxidant-production in human atherosclerotic carotid plaques. Histol Histopathol 26:1\u201311","journal-title":"Histol Histopathol"},{"key":"4061_CR76","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.injury.2015.03.028","volume":"46","author":"J Hazeldine","year":"2015","unstructured":"Hazeldine J, Hampson P, Opoku FA et al (2015) N-Formyl peptides drive mitochondrial damage associated molecular pattern induced neutrophil activation through ERK1\/2 and P38 MAP kinase signalling pathways. Injury 46:975\u2013984. https:\/\/doi.org\/10.1016\/j.injury.2015.03.028","journal-title":"Injury"},{"key":"4061_CR77","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1242\/jcs.182097","volume":"129","author":"A Yurdagul","year":"2016","unstructured":"Yurdagul A, Sulzmaier FJ, Chen XL et al (2016) Oxidized LDL induces FAK-dependent RSK signaling to drive NF-\u03baB activation and VCAM-1 expression. J Cell Sci 129:1580\u20131591. https:\/\/doi.org\/10.1242\/jcs.182097","journal-title":"J Cell Sci"},{"key":"4061_CR78","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11883-017-0678-6","volume":"19","author":"AJ Kattoor","year":"2017","unstructured":"Kattoor AJ, Pothineni NVK, Palagiri D, Mehta JL (2017) Oxidative stress in atherosclerosis. Curr Atheroscler Rep 19:42. https:\/\/doi.org\/10.1007\/s11883-017-0678-6","journal-title":"Curr Atheroscler Rep"},{"key":"4061_CR79","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.immuni.2017.09.010","volume":"47","author":"I Zanoni","year":"2017","unstructured":"Zanoni I, Tan Y, Di Gioia M et al (2017) By capturing inflammatory lipids released from dying cells, the receptor CD14 induces inflammasome-dependent phagocyte hyperactivation. Immunity 47:697\u2013709. e3. https:\/\/doi.org\/10.1016\/j.immuni.2017.09.010","journal-title":"Immunity"},{"key":"4061_CR80","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.freeradbiomed.2019.04.004","volume":"136","author":"H Jin","year":"2019","unstructured":"Jin H, Ko YS, Park SW, Kim HJ (2019) P2Y2R activation by ATP induces oxLDL-mediated inflammasome activation through modulation of mitochondrial damage in human endothelial cells. Free Radic Biol Med 136:109\u2013117. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.04.004","journal-title":"Free Radic Biol Med"},{"key":"4061_CR81","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1007\/s00018-012-1194-z","volume":"70","author":"S Xu","year":"2013","unstructured":"Xu S, Ogura S, Chen J et al (2013) LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell Mol Life Sci 70:2859\u20132872. https:\/\/doi.org\/10.1007\/s00018-012-1194-z","journal-title":"Cell Mol Life Sci"},{"key":"4061_CR82","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1073\/pnas.97.4.1743","volume":"97","author":"H Deguchi","year":"2000","unstructured":"Deguchi H, Fern\u00e1ndez JA, Hackeng TM et al (2000) Cardiolipin is a normal component of human plasma lipoproteins. PNAS 97:1743\u20131748. https:\/\/doi.org\/10.1073\/pnas.97.4.1743","journal-title":"PNAS"},{"key":"4061_CR83","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1161\/ATVBAHA.114.304342","volume":"35","author":"A Liu","year":"2015","unstructured":"Liu A, Ming JY, Fiskesund R et al (2015) Induction of dendritic cell\u2013mediated T-cell activation by modified but not native low-density lipoprotein in humans and inhibition by Annexin A5. Arterioscler Thromb Vasc Biol 35:197\u2013205. https:\/\/doi.org\/10.1161\/ATVBAHA.114.304342","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4061_CR84","doi-asserted-by":"publisher","first-page":"e003976","DOI":"10.1161\/JAHA.116.003976","volume":"5","author":"J Frosteg\u00e5rd","year":"2016","unstructured":"Frosteg\u00e5rd J, Zhang Y, Sun J et al (2016) Oxidized Low-Density Lipoprotein (OxLDL)\u2013treated dendritic cells promote activation of T cells in human atherosclerotic plaque and blood, which is repressed by statins: microRNA let-7c Is integral to the effect. J Am Heart Assoc 5:e003976. https:\/\/doi.org\/10.1161\/JAHA.116.003976","journal-title":"J Am Heart Assoc"},{"key":"4061_CR85","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.atherosclerosis.2010.06.007","volume":"212","author":"X Lu","year":"2010","unstructured":"Lu X, Chen D, Endresz V et al (2010) Immunization with a combination of ApoB and HSP60 epitopes significantly reduces early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her\/J mice. Atherosclerosis 212:472\u2013480. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.06.007","journal-title":"Atherosclerosis"},{"key":"4061_CR86","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/cvr\/cvp036","volume":"82","author":"L Sun","year":"2009","unstructured":"Sun L, Ishida T, Yasuda T et al (2009) RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice. Cardiovasc Res 82:371\u2013381. https:\/\/doi.org\/10.1093\/cvr\/cvp036","journal-title":"Cardiovasc Res"},{"key":"4061_CR87","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2014.01.022","volume":"69","author":"SY Eun","year":"2014","unstructured":"Eun SY, Park SW, Lee JH et al (2014) P2Y2R activation by nucleotides released from oxLDL-treated endothelial cells (ECs) mediates the interaction between ECs and immune cells through RAGE expression and reactive oxygen species production. Free Radic Biol Med 69:157\u2013166. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.01.022","journal-title":"Free Radic Biol Med"},{"key":"4061_CR88","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/cvr\/cvq191","volume":"88","author":"AR Bachar","year":"2010","unstructured":"Bachar AR, Scheffer L, Schroeder AS et al (2010) Humanin is expressed in human vascular walls and has a cytoprotective effect against oxidized LDL-induced oxidative stress. Cardiovasc Res 88:360\u2013366. https:\/\/doi.org\/10.1093\/cvr\/cvq191","journal-title":"Cardiovasc Res"},{"key":"4061_CR89","doi-asserted-by":"publisher","unstructured":"Zacharias DG, Kim SG, Massat AE et al (2012) Humanin, a cytoprotective peptide, is expressed in carotid artherosclerotic plaques in humans. PLoS One 7. https:\/\/doi.org\/10.1371\/journal.pone.0031065","DOI":"10.1371\/journal.pone.0031065"},{"key":"4061_CR90","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbrc.2016.10.138","volume":"482","author":"W Zhu","year":"2017","unstructured":"Zhu W, Wang S, Liu Z et al (2017) Gly[14]-humanin inhibits ox-LDL uptake and stimulates cholesterol efflux in macrophage-derived foam cells. Biochem Biophys Res Commun 482:93\u201399. https:\/\/doi.org\/10.1016\/j.bbrc.2016.10.138","journal-title":"Biochem Biophys Res Commun"},{"key":"4061_CR91","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.trsl.2019.08.003","volume":"215","author":"M Satish","year":"2020","unstructured":"Satish M, Agrawal DK (2020) Atherothrombosis and the NLRP3 inflammasome \u2013 endogenous mechanisms of inhibition. Transl Res 215:75\u201385. https:\/\/doi.org\/10.1016\/j.trsl.2019.08.003","journal-title":"Transl Res"},{"key":"4061_CR92","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.biopha.2016.04.043","volume":"82","author":"F Kong","year":"2016","unstructured":"Kong F, Ye B, Lin L et al (2016) Atorvastatin suppresses NLRP3 inflammasome activation via TLR4\/MyD88\/NF-\u03baB signaling in PMA-stimulated THP-1 monocytes. Biomed Pharmacother 82:167\u2013172. https:\/\/doi.org\/10.1016\/j.biopha.2016.04.043","journal-title":"Biomed Pharmacother"},{"key":"4061_CR93","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1124\/mol.116.108100","volume":"92","author":"S Wang","year":"2017","unstructured":"Wang S, Xie X, Lei T et al (2017) Statins attenuate activation of the NLRP3 inflammasome by oxidized LDL or TNF\u03b1 in vascular endothelial cells through a PXR-dependent mechanism. Mol Pharmacol 92:256\u2013264. https:\/\/doi.org\/10.1124\/mol.116.108100","journal-title":"Mol Pharmacol"},{"key":"4061_CR94","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejphar.2019.03.006","volume":"852","author":"L Zhang","year":"2019","unstructured":"Zhang L, Lu L, Zhong X et al (2019) Metformin reduced NLRP3 inflammasome activity in Ox-LDL stimulated macrophages through adenosine monophosphate activated protein kinase and protein phosphatase 2A. Eur J Pharmacol 852:99\u2013106. https:\/\/doi.org\/10.1016\/j.ejphar.2019.03.006","journal-title":"Eur J Pharmacol"},{"key":"4061_CR95","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T et al (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377:1119\u20131131. https:\/\/doi.org\/10.1056\/NEJMoa1707914","journal-title":"N Engl J Med"},{"key":"4061_CR96","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2017.12.027","volume":"269","author":"GJ Mart\u00ednez","year":"2018","unstructured":"Mart\u00ednez GJ, Celermajer DS, Patel S (2018) The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation. Atherosclerosis 269:262\u2013271. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.12.027","journal-title":"Atherosclerosis"},{"key":"4061_CR97","doi-asserted-by":"publisher","first-page":"e002128","DOI":"10.1161\/JAHA.115.002128","volume":"4","author":"GJ Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez GJ, Robertson S, Barraclough J et al (2015) Colchicine acutely suppresses local cardiac production of inflammatory cytokines in patients with an acute coronary syndrome. J Am Heart Assoc 4:e002128. https:\/\/doi.org\/10.1161\/JAHA.115.002128","journal-title":"J Am Heart Assoc"},{"key":"4061_CR98","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1042\/CS20160090","volume":"130","author":"S Robertson","year":"2016","unstructured":"Robertson S, Mart\u00ednez GJ, Payet CA et al (2016) Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation. Clin Sci (Lond) 130:1237\u20131246. https:\/\/doi.org\/10.1042\/CS20160090","journal-title":"Clin Sci (Lond)"},{"key":"4061_CR99","doi-asserted-by":"publisher","first-page":"114246","DOI":"10.1016\/j.bcp.2020.114246","volume":"182","author":"JB Nyandwi","year":"2020","unstructured":"Nyandwi JB, Ko YS, Jin H et al (2020) Rosmarinic acid inhibits oxLDL-induced inflammasome activation under high-glucose conditions through downregulating the p38-FOXO1-TXNIP pathway. Biochem Pharmacol 182:114246. https:\/\/doi.org\/10.1016\/j.bcp.2020.114246","journal-title":"Biochem Pharmacol"},{"key":"4061_CR100","doi-asserted-by":"publisher","unstructured":"Kong F, Ye B, Cao J et al (2016) Curcumin represses NLRP3 inflammasome activation via TLR4\/MyD88\/NF-\u03baB and P2X7R signaling in PMA-induced macrophages. Front Pharmacol 7. https:\/\/doi.org\/10.3389\/fphar.2016.00369","DOI":"10.3389\/fphar.2016.00369"},{"key":"4061_CR101","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1161\/CIRCRESAHA.116.308362","volume":"119","author":"G Tumurkhuu","year":"2016","unstructured":"Tumurkhuu G, Shimada K, Dagvadorj J et al (2016) Ogg1-Dependent DNA repair regulates NLRP3 inflammasome and prevents atherosclerosis. Circ Res 119:e76\u2013e90. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308362","journal-title":"Circ Res"},{"key":"4061_CR102","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.immuni.2015.10.018","volume":"43","author":"Z Zhang","year":"2015","unstructured":"Zhang Z, Meng P, Han Y et al (2015) Mitochondrial DNA-LL-37 complex promotes atherosclerosis by escaping from autophagic recognition. Immunity 43:1137\u20131147. https:\/\/doi.org\/10.1016\/j.immuni.2015.10.018","journal-title":"Immunity"},{"key":"4061_CR103","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.tibs.2011.09.003","volume":"37","author":"SM Claypool","year":"2012","unstructured":"Claypool SM, Koehler CM (2012) The complexity of cardiolipin in health and disease. Trends Biochem Sci 37:32\u201341. https:\/\/doi.org\/10.1016\/j.tibs.2011.09.003","journal-title":"Trends Biochem Sci"},{"key":"4061_CR104","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/sj.cdd.4402135","volume":"14","author":"M Ott","year":"2007","unstructured":"Ott M, Zhivotovsky B, Orrenius S (2007) Role of cardiolipin in cytochrome c release from mitochondria. Cell Death Differ 14:1243\u20131247. https:\/\/doi.org\/10.1038\/sj.cdd.4402135","journal-title":"Cell Death Differ"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-021-04061-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T11:53:04Z","timestamp":1615204384000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-021-04061-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":104,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["4061"],"URL":"https:\/\/doi.org\/10.1007\/s11010-021-04061-0","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,25]]},"assertion":[{"value":"3 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standard"}},{"value":"The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}